"Centrum Medyczne "SOPMED" Sp. z o.o. jest podmiotem leczniczym , który świadczy usługi z zakresu podstawowej opieki zdrowotnej , specjalistycznej opieki zdrowotnej , szpitalnej (chemioterapia jednego dnia) , diagnostyki oraz medycyny pracy."

During the past decade, ENDOSKOPIA Sp.zo.o conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "ENDOSKOPIA Sp.zo.o" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "ENDOSKOPIA Sp.zo.o" are "Ulcerative Colitis" (3 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "ENDOSKOPIA Sp.zo.o" in a lesser frequency.

Most popular intervention types in "ENDOSKOPIA Sp.zo.o" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Etrasimod" (3 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "ENDOSKOPIA Sp.zo.o" are 5 trials for "All" genders.

Currently, there are NaN active trials in "ENDOSKOPIA Sp.zo.o". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in ENDOSKOPIA Sp.zo.o, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in ENDOSKOPIA Sp.zo.o, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".